VIR Company Profile and Key Details

Q: Who are the executives of VIR?

Mr. Howard HornExecutive Vice President, Chief Financial Officer & Sec.Cara MillerVice President of Corporation CommunicationsDr. Louis J. Picker M.D.Co-Founder & Scientific AdvisorMr. Steven J. RiceExecutive Vice President & Chief Admin. OfficerDr. George A. Scangos Ph.D.Pres, Chief Executive Officer & DirectorMs. Johanna Friedl-NadererExecutive Vice President & Chief Operating OfficerDr. Ann M. Hanly Ph.D.Executive Vice President & Chief Technology OfficerDr. Phillip Pang M.D., Ph.D.Executive Vice President, Chief Medical Officer & Interim Head of ResearchDr. Marianne De Backer M.B.A., M.Sc., Ph.D.Chief Executive Officer & DirectorDr. Klaus Frueh Ph.D.Co-Founder & Scientific AdvisorDr. Lawrence Corey M.D.Co-Founder & Scientific AdvisorMs. Heather Rowe ArmstrongVice President of Investor RelationsMs. Vanina De Verneuil J.D.Senior Vice President of Legal & Corporation Sec.

NASDAQ : VIR

Vir Biotechnology

$8.25

-0.26-3.06%

At Close 4:00 PM

55.71

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Vir Biotechnology, Inc. (VIR) stock declined over -3.06%, trading at $8.25 on NASDAQ, down from the previous close of $8.51. The stock opened at $8.52, fluctuating between $8.17 and $8.65 in the recent session.

Stock Snapshot

8.51

Prev. Close

1.39B

Market Cap

8.165

Day Low

-2.64

P/E Ratio

-3.13

EPS (TTM)

-5.95

Cash Flow per Share

8.52

Open

168.65M

Number of Shares

8.65

Day High

68.08%

Free Float in %

11.81

Book Value

1.67M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 10, 2026	8.46	8.65	8.16	8.25	1.71M
Jun 09, 2026	8.62	8.73	8.24	8.51	1.66M
Jun 08, 2026	8.74	8.92	8.39	8.45	1.33M
Jun 05, 2026	9.09	9.19	8.63	8.65	1.33M
Jun 04, 2026	8.91	9.29	8.91	9.15	1.44M
Jun 03, 2026	8.87	9.03	8.68	8.77	2.34M
Jun 01, 2026	9.34	9.49	9.02	9.03	1.74M
May 29, 2026	9.51	9.91	9.47	9.54	3.09M
May 28, 2026	9.02	9.64	8.86	9.55	2.29M
May 27, 2026	9.45	9.54	9.08	9.10	1.39M
May 26, 2026	9.24	9.57	9.16	9.38	1.14M
May 22, 2026	9.07	9.29	9.03	9.19	1.19M
May 21, 2026	8.78	9.18	8.70	9.03	957.37K
May 20, 2026	8.64	8.98	8.60	8.88	1.93M
May 19, 2026	8.69	8.83	8.52	8.53	1.85M
May 18, 2026	8.77	8.87	8.55	8.77	1.52M
May 15, 2026	8.96	8.98	8.64	8.79	1.71M
May 14, 2026	9.34	9.39	8.92	9.09	1.55M
May 13, 2026	9.37	9.45	9.16	9.33	1.21M
May 12, 2026	9.32	9.57	9.19	9.40	1.23M

Contact Details

San Francisco, CA 94158

United States

https://www.vir.bio 415 906 4324

About Company

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Stock Peers

ARGX

-21.82-2.47%

argenx SE$862.18 REGN

-14.53-2.36%

Regeneron Pharmaceuticals, Inc.$601.65 UTHR

-9.04-1.63%

United Therapeutics Corporation$544.10 MDGL

-5.57-1.17%

Madrigal Pharmaceuticals, Inc.$471.32 VRTX

-10.06-2.26%

Vertex Pharmaceuticals Incorporated$435.71 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

2.66+0.86%

Krystal Biotech, Inc.$312.41 ALNY

-6.47-2.17%

Alnylam Pharmaceuticals, Inc.$291.22 LGND

4.96+2.04%

Ligand Pharmaceuticals Incorporated$248.24 AXSM

0.7+0.28%

Axsome Therapeutics, Inc.$246.34

Frequently Asked Questions

What is the current Vir Biotechnology, Inc. (VIR) stock price?

Vir Biotechnology, Inc. (NASDAQ: VIR) stock price is $8.25 in the last trading session. During the trading session, VIR stock reached the peak price of $8.65 while $8.17 was the lowest point it dropped to. The percentage change in VIR stock occurred in the recent session was -3.06% while the dollar amount for the price change in VIR stock was - $0.26.

VIR's industry and sector of operation?

The NASDAQ listed VIR is part of Biotechnology industry that operates in the broader Healthcare sector. Vir Biotechnology, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VIR?

Mr. Howard Horn
Executive Vice President, Chief Financial Officer & Sec.
Cara Miller
Vice President of Corporation Communications
Dr. Louis J. Picker M.D.
Co-Founder & Scientific Advisor
Mr. Steven J. Rice
Executive Vice President & Chief Admin. Officer
Dr. George A. Scangos Ph.D.
Pres, Chief Executive Officer & Director
Ms. Johanna Friedl-Naderer
Executive Vice President & Chief Operating Officer
Dr. Ann M. Hanly Ph.D.
Executive Vice President & Chief Technology Officer
Dr. Phillip Pang M.D., Ph.D.
Executive Vice President, Chief Medical Officer & Interim Head of Research
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Chief Executive Officer & Director
Dr. Klaus Frueh Ph.D.
Co-Founder & Scientific Advisor
Dr. Lawrence Corey M.D.
Co-Founder & Scientific Advisor
Ms. Heather Rowe Armstrong
Vice President of Investor Relations
Ms. Vanina De Verneuil J.D.
Senior Vice President of Legal & Corporation Sec.

How VIR did perform over past 52-week?

VIR's closing price is 98.56% higher than its 52-week low of $4.16 where as its distance from 52-week high of $11.66 is -29.25%.

How many employees does VIR have?

Number of VIR employees currently stands at 408.

Link for VIR official website?

Official Website of VIR is: https://www.vir.bio

How do I contact VIR?

VIR could be contacted at phone 415 906 4324 and can also be accessed through its website. VIR operates from 499 Illinois Street, San Francisco, CA 94158, United States.

How many shares of VIR are traded daily?

VIR stock volume for the day was 1.67M shares. The average number of VIR shares traded daily for last 3 months was 1.85M.

What is the market cap of VIR currently?

The market value of VIR currently stands at $1.39B with its latest stock price at $8.25 and 168.65M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	408
Beta	1.71
Sales or Revenue	$86.18M
5Y Sales Change%	70.736%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	408
Beta	1.71
Sales or Revenue	$86.18M
5Y Sales Change%	70.736%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

VIR Company Profile and Key Details

Vir Biotechnology

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Valuation Metrics

Price Forecast & Outlook

Key Takeaways